TITLE

Relationship of shuttle walk test and lung cancer surgical outcome

AUTHOR(S)
Win, Thida; Jackson, Arlene; Groves, Ashley M.; Wells, Francis C.; Ritchie, Andrew J.; Munday, Helen; Laroche, Clare M.
PUB. DATE
December 2004
SOURCE
European Journal of Cardio-Thoracic Surgery;Dec2004, Vol. 26 Issue 6, p1216
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Abstract: Objective: Surgery remains the treatment of choice in patients with potentially resectable lung carcinoma. Both the British Thoracic Society and American Chest Physician guidelines for the selection of patients with lung cancer surgery suggest the use of a shuttle walk test to predict outcome in patients with borderline lung function. The guidelines suggest that if the patient is unable to walk 250m during a shuttle walk test, they are high risk for surgery. However, there is no published evidence to support this recommendation. Therefore, we undertook a prospective study to examine the relationship between shuttle walk test and surgical outcome in 139 patients undergoing assessment for possible lung cancer surgery. Methods: The shuttle walk test was performed in 139 potentially resectable patients, recruited over a 2 year period, prior to surgery. One hundred and eleven patients underwent surgery. Outcome of surgery, including duration of hospital stay, complication and mortality rates was recorded. Student''s t-test was used to compare the shuttle walk distance in patients with good and poor outcome from surgery. Results: Mean age of patients undergoing surgery was 69 years (42–85). Mean shuttle walk distance was 395m (145–780), with a mean oxygen desaturation of 4% (0–14) during the test. Sixty nine patients had a good surgical outcome and 34 had a poor outcome. The shuttle walk distance was not statistically different in the two outcome groups. Conclusion: Shuttle walk distance should not be used to predict poor surgical outcome in lung cancer patients, contrary to current recommendations. It is therefore advisable to perform a formal cardiopulmonary exercise test if at all possible. The usefulness of a shuttle walk test might be improved. It could be compared to a predicted value, as for a formal cardiopulmonary exercise test.
ACCESSION #
15430153

 

Related Articles

  • Evolution in surgical approach and techniques for lung cancer. Ng, Calvin S. H.; Lau, Kelvin K. W.; Gonzalez-Rivas, Diego; Rocco, Gaetano // Thorax;Jul2013, Vol. 68 Issue 7, p681 

    A letter to the editor in response to the article "Therapeutic advances in non-small cell lung cancer" by E. Vallieres, S. Peters and P. Van Houtte is presented.

  • Predicting the Mortality Benefit of CT Screening for Second Lung Cancer in a High-Risk Population. Kinsey, C. Matthew; Hamlington, Katharine L.; O’Toole, Jacqueline; Stapleton, Renee; Bates, Jason H. T. // PLoS ONE;11/2/2016, Vol. 11 Issue 11, p1 

    Patients who survive an index lung cancer (ILC) after surgical resection continue to be at significant risk for a metachronous lung cancer (MLC). Indeed, this risk is much higher than the risk of developing an ILC in heavy smokers. There is currently little evidence upon which to base guidelines...

  • Whose risk is it anyway? Waller, David A. // Thorax;Sep2013, Vol. 68 Issue 9, p799 

    The author discusses the significance of 90-day mortality after lung cancer surgery, as describes by a research conducted by H. Powell and colleagues. The author further discusses merits and demerits of 90-day mortality approach in terms of side effects of adjuvant chemotherapy,...

  • Is limited surgery recommended if nodal involvement cannot be ruled out? Baisi, Alessandro; Raveglia, Federico; De Simone, Matilde; Cioffi, Ugo; Aritoshi Hattori; Kenji Suzuki; Kazuya Takamochi; Shiaki Oh // European Journal of Cardio-Thoracic Surgery;Sep2015, Vol. 48 Issue 3, p517 

    A letter to the editor is presented in response to an article on the appropriate operative strategy for patients with sub-centimeter solid lung cancer.

  • Actualités en pathologie moléculaire dans les cancers du poumon non à petites cellules. Lantuejoul, S.; Mescam-Mancini, L.; Burroni, B.; McLeer-Florin, A. // Oncologie;Sep2012, Vol. 14 Issue 9, p530 

    Lung cancer is the leading cause of death by cancer worldwide. The vast majority of lung tumors are non-small cell lung carcinomas (NSCLC), and surgical resection remains the only effective treatment. According to the new WHO histological classification of lung cancer, NSCLC comprise three major...

  • Early mortality after surgical resection for lung cancer: an analysis of the English National Lung cancer audit. Powell, Helen A.; Tata, Laila J.; Baldwin, David R.; Stanley, Rosamund A.; Khakwani, Aamir; Hubbard, Richard B. // Thorax;Sep2013, Vol. 68 Issue 9, p826 

    Introduction: For appropriately staged non-small cell lung cancer (NSCLC) surgical resection can dramatically improve survival, but some may not be offered this treatment because of concerns about perioperative mortality. Methods: We used data from the National Lung Cancer Audit (NLCA) to...

  • Causes of death within 1 year of resection for lung cancer. Early mortality after resection. Toker, Alper; Dilege, Sukru; Ziyade, Sedat; Eroglu, Osman; Tanju, Serhan; Yilmazbayhan, Dilek; Kilicarslan, Zeki; Kalayci, Goksel // European Journal of Cardio-Thoracic Surgery;Apr2004, Vol. 25 Issue 4, p515 

    Objectives: Some of the lung cancer patients who are treated surgically with curative intent ultimately die in the early postoperative period. The aim of this study is to analyze the causes of death within 1 year of resection for lung cancer in our patients. Methods: Six hundred and twenty...

  • Nearly Half of Lung Cancer Surgery Patients Continue Smoking.  // Pulmonary Reviews;Jan2007, Vol. 12 Issue 1, p1 

    The article discusses research being done on smoking relapse during the first year after treatment for early stage non-small-cell lung cancer. It references a study by M. S. Walker et al published in a 2006 issue of the journal "Cancer Epidemial Biomarkers." Almost half of the patients included...

  • The Role of KRAS Mutational Analysis to Determine the Site of Origin of Metastatic Carcinoma to the Lung: A Case Report. Ahmed, N. Alkhasawneh; Dong, Hui-Jia; Liu, Chen; Allegra, Carmen; Allan, Robert W. // Case Reports in Pathology;2012, p1 

    Metastatic carcinomas involving the lung are a common specimen encountered in surgical pathology. These metastases may have different morphologic, and architectural patterns and may mimic primary pulmonary adenocarcinoma, especially the intraalveolar (lepidic) pattern of spread which may...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics